Clinical Trial Update: An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II [Phase 3]

View source ↗

Summary

An extension Phase 3 study is evaluating the safety and efficacy of AVTX-803 in subjects with Leukocyte Adhesion Deficiency Type II.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukocyte Adhesion Deficiency Type Ii

Drugs mentioned

• AVTX-803

Snippet

Sponsor: AUG Therapeutics | Conditions: Leukocyte Adhesion Deficiency | Phase 3 | Status: UNKNOWN